- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: epratuzumab
Total 327 results
-
UCB PharmaCompletedSystemic Lupus ErythematosusJapan
-
Nantes University HospitalUnknown
-
Charite University, Berlin, GermanyEuropean Organisation for Research and Treatment of Cancer - EORTC; Centre... and other collaboratorsCompletedAcute Lymphoblastic Leukemia (ALL)United Kingdom, Norway, Germany, Italy, France, Belgium, Denmark, Australia, Austria, Czechia, Finland, Israel, Japan, Netherlands, Poland, Portugal, Switzerland
-
UCB Biopharma S.P.R.L.Pharmaceutical Research Associates; Richmond Pharmacology Limited; Eurofins; ACM... and other collaboratorsCompletedSystemic Lupus ErythematosusUnited Kingdom
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
UCB PharmaTerminatedLupus Erythematosus, SystemicUnited States
-
UCB PharmaTerminatedSystemic Lupus ErythematosusUnited States, Belgium, Netherlands, United Kingdom, Spain, Hungary
-
AmgenCompletedNon-Hodgkin's Lymphoma
-
National Institute of Arthritis and Musculoskeletal...Completed
-
Gilead SciencesCompletedLymphoma, B-Cell | Non-Hodgkin's Lymphoma
-
Gilead SciencesTerminated
-
Gilead SciencesUnknownLymphomaSwitzerland, United States, Italy, Sweden, Austria
-
Gilead SciencesUnknownLymphomaSwitzerland, United States, Italy, Sweden, Austria
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
Gilead SciencesCompleted
-
Garden State Cancer Center at the Center for Molecular...National Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
Shanghai Henlius BiotechCompletedHealthy Male VolunteersChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Zydus Lifesciences LimitedNot yet recruiting
-
Queen Mary University of LondonGilead SciencesUnknownRecurrent or Refractory B Cell Acute Lymphoblastic LeukaemiaUnited Kingdom
-
Gilead SciencesWithdrawnDiffuse Large B-cell Lymphoma | NHL | Non Hodgkin's Lymphoma | Aggressive NHLUnited States
-
Shengjing HospitalNot yet recruiting
-
Gilead SciencesTerminatedWaldenstrom MacroglobulinemiaUnited States
-
UCB PharmaWithdrawnSystemic Lupus ErythematosusUnited States, France, United Kingdom, Spain, Belgium, Netherlands, Canada, Brazil, Germany, Hungary, Czech Republic, Italy, Slovakia
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Poland, Spain, Belgium, India, Ukraine, Brazil, United Kingdom, Hungary, Lithuania, Hong Kong
-
European Organisation for Research and Treatment...Hoffmann-La RocheCompletedElderly Metastatic Breast Cancer PopulationBelgium, Italy, Netherlands, France, Poland, United Kingdom, Portugal, Sweden
-
UCB PharmaCompletedSystemic Lupus ErythematosusJapan
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Brazil, Canada, France, Germany, Hungary, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom, Australia, Belgium, Bulgaria, Czechia, Estonia, Israel, Korea, Republic of, T... and more
-
Genentech, Inc.Completed
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Poland, Spain, Belgium, India, Ukraine, Brazil, United Kingdom, Hungary, Lithuania, Hong Kong
-
Nantes University HospitalWithdrawnCD22+ Relapsed/Refractory B-ALLFrance
-
Genentech, Inc.Completed
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Australia, Belgium, Brazil, Bulgaria, Czechia, Estonia, France, Germany, India, Israel, Italy, Korea, Republic of, Lithuania, Mexico, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, United Kingdom
-
UCB PharmaTerminatedSystemic Lupus ErythematosusUnited States, France, United Kingdom, Spain, Belgium, Netherlands, Canada, Brazil, Germany, Czech Republic, Italy
-
BiocadRecruitingBreast CancerRussian Federation
-
Ontario Clinical Oncology Group (OCOG)Terminated
-
UCB PharmaCompleted
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
BiocadActive, not recruiting
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
Nantes University HospitalGilead Sciences; Institut Cancerologie de l'OuestWithdrawnLymphocyte B CD22 Positive Acute Lymphoblastic Leukemia
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)RecruitingHER2-positive Metastatic Breast Cancer | HER-2 Protein Overexpression | HER-2 Positive Malignant Carcinoma of BreastUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHER2-positive Carcinoma | HER2-positive Primary MalignancyUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Roche Pharma AGCompletedEsophageal CarcinomaNetherlands
-
Fudan UniversityCompleted
-
Hospices Civils de LyonNot yet recruiting
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Weill Medical College of Cornell UniversityGilead SciencesTerminatedFollicular LymphomaUnited States
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina